W

Wellington Management

Global asset management for institutional clients

Senior Systems Analyst - Post-Trade Settlements

Full-TimeUpdated on 10/22/2026
$80k - $150k+ Discretionary Corporate Bonus + Incentives
Senior
Bachelor's
Boston, MA, USA
HybridOffice work 4 days a week; remote work 1 day a week.
Business & StrategyBusiness Analysis
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in Computer Science, Business, Economics, Finance, or a related subject.
  • At least 5 years of business analysis or systems analysis experience.
  • Strong hands-on SQL skills, including writing queries against relational databases to investigate production issues, reconcile data across systems, and uncover root causes.
  • Demonstrated interest in using artificial intelligence and advanced tooling to enhance business analysis workflows, including requirements development, data exploration, testing, and knowledge discovery.
  • Understanding of financial instruments such as equities, bonds, swaps, options, futures, forwards, and foreign exchange, and of their post-trade lifecycle, including allocation, confirmation, settlement, and fails management.
  • Excellent verbal and written presentation and communication skills.
  • Strong analytical and problem-solving skills, with high attention to detail.
  • Strong client relationship skills and the ability to build consensus.
  • A blend of business and technical knowledge, a broad perspective, and the ability to work with internal teams to execute on that vision, along with a working understanding of application construction—including databases, interfaces, data flows, and batch versus real-time processing—sufficient to brainstorm and design workflows with developers.
  • Experience working directly with business partners to understand their needs and deliver solutions, ideally in trade operations, settlements, or another middle- or back-office environment.
  • Experience writing requirements, functional specifications, use cases, and test plans.
  • Experience in IT change, incident, and problem management, and the software development life cycle.
  • Experience using project tracking tools such as Jira or ServiceNow.
  • Experience supporting critical production applications.
  • Ability to work independently in a fast-paced, business-critical, team-oriented environment.
  • Intellectual curiosity about business partners' work and willingness to learn independently and from peers.
Responsibilities
  • Manage production incidents by querying production data with SQL, tracing issues end to end, determining root causes and corrective actions, and following up.
  • Interact directly with business partners at all organizational levels to define, analyze, and document requirements and set priorities.
  • Advocate for and advise business partners on their needs.
  • Develop expertise in firm-specific workflows, including the trade confirmation and settlement lifecycle and the rationale behind operational procedures, market conventions, and controls.
  • Observe Settlements and Operations analysts' processes firsthand and use that understanding to anticipate pain points and propose solutions proactively.
  • Author functional, design, and support documentation.
  • Collaborate with software developers, database architects, vendors, and IT and business teams to analyze and determine functional specifications and user-interface design for new applications and enhancements, and help shape workflows based on an understanding of applications, data flows, and interfaces.
  • Partner with the delivery team to ensure timely, scalable, high-quality business solutions.
  • Provide regular project status reports and track issues.
  • Provide input on system design to help the development team define effort and implementation schedules.
  • Oversee phases of testing and user acceptance.
  • Provide rotational production support to business users and act as an escalation point for support issues requiring detailed analysis and management.
  • Perform vendor and broker management tasks, work with the business team on project work and enhancements, and raise defects on vendor platforms.
Desired Qualifications
  • Experience working directly with business partners to understand their needs and deliver solutions, ideally in trade operations, settlements, or another middle- or back-office environment.

About the company

Wellington Management is a global investment management firm that offers equity, fixed income, multi-asset, and alternative investments to both institutional clients (such as pension funds, endowments, foundations, and insurers) and individual investors. It manages assets on behalf of clients, earning fees based on assets under management (AUM) and on investment performance. The firm relies on deep research capabilities and market insights to tailor investment strategies that meet client needs, and it integrates environmental, social, and governance (ESG) factors into its process. What sets Wellington Management apart is its broad suite of investment options combined with a commitment to ESG integration and a client-tailored approach, supported by a culture that emphasizes diversity and inclusion. The company’s goal is to help clients achieve their investment objectives by delivering disciplined, research-driven strategies and sustainable investing over the long term.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

$65.9B

Headquarters

Boston, Massachusetts

Founded

1933

Get referred to Wellington Management

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Hartford Funds acquisition closes in first quarter 2027, adding wealth distribution.
  • The new Wellington-Vanguard-Blackstone solutions expand access to public-private portfolios.
  • Wellington’s venture, biotech, climate, and CLO launches broaden fee-bearing alternatives.

What critics are saying

  • Hartford Funds integration carries execution risk until regulators approve the Q1 2027 close.
  • Steve Klar’s retirement in June 2026 exposes client-platform succession risk.
  • Passive giants and private-credit rivals compress Wellington’s fees and threaten AUM growth.

What makes Wellington Management unique

  • Wellington blends public and private markets through alliances with Vanguard and Blackstone.
  • Its $1.35 trillion platform spans 60 countries and over 2,500 institutional clients.
  • Matt Witheiler’s Forbes Midas List streak validates Wellington’s late-stage growth investing credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Comprehensive health coverage
  • Work-life balance
  • Financial future
  • Development

Company News

The Information
Oct 15th, 2026
Mueon raises $65M to pack up to 10x more AI computing into data centres

Portland-based startup Mueon has raised $65 million to develop a new way to arrange AI server rack components. The company says its design could fit up to 10 times more computing capacity into the same amount of power as existing data centre setups. The approach could ease constraints on global computing capacity.

Business Wire
Oct 13th, 2026
Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program

Edgewise Therapeutics, a clinical-stage biopharmaceutical company developing orally bioavailable, small molecule therapies for musculoskeletal diseases, toda...

MarketScreener
Oct 13th, 2026
Alaunos Therapeutics to raise $350M in private placement led by Fairmount

Alaunos Therapeutics has agreed to raise about $349.95 million through a private placement of stock. It signed a Securities Purchase Agreement to sell 687,789 shares of common stock at $1.4357 per share and 243,063 shares of Series C preferred stock at $1,435.70 per share. The common stock brings in about $987,459, and the preferred stock about $348.97 million. The deal is expected to close on October 14, 2026, subject to customary closing conditions. Fairmount led the placement of Series C non-voting convertible preferred stock. Venrock Healthcare Capital Partners, T. Rowe Price Investment Management, Wellington Management, Janus Henderson Investors, Access Biotechnology, BB Biotech, Perceptive Advisors, Sirenia Capital Management, ADAR1 Capital Management and other firms took part.

LinkedIn
Sep 30th, 2026
We just closed an employee tender offer which values ElevenLabs at $22BN, up 2x from our Series D in February. The tender was led by Wellington and T. Rowe Price, and the growth is driven by demand… | Mati Staniszewski | 89 comments

We just closed an employee tender offer which values ElevenLabs at $22BN, up 2x from our Series D in February. The tender was led by Wellington and T. Rowe Price, and the growth is driven by demand from enterprises to deploy ElevenAgents across sales, support, and operations. In 2022, we raised our first round at a $9 million valuation, which we announced alongside Eleven v1, our first Text to Speech model, and the first model to generate human-level speech. Four years later, as we reach our new valuation, we just released two new state-of-the-art Text to Speech models. Eleven v4 and v4 Turbo are our fastest and most emotive models yet, and are leading independent benchmarks. Alongside models, we have built a full interaction platform for AI. It allows organizations to deploy conversational agents, connected to their knowledge and systems, that interact naturally in any industry, geography, or context. This shift is driving much of our growth, with enterprise now accounting for 55% of our revenue, as businesses adopt ElevenAgents to support their customers and employees. Our technology is now used in daily operations at five of the world’s ten largest tech companies, five of the ten largest insurers, and four of the ten largest telecoms. The round was co-led by Wellington Management and T. Rowe Price, along with participation from Goldman Sachs, GIC, Ontario Teachers'​ Pension Plan, EQT Group, Sapphire Ventures, and BDT & MSD Partners. And grateful for ongoing support from existing investors including Andreessen Horowitz, Alkeon Capital, The D. E. Shaw Group, Disruptive, Evantic Capital, ICONIQ, and Lightspeed. Most of all, this round is for the team that built the last four years. We're just getting started! | 89 comments on LinkedIn

MarketScreener
Sep 29th, 2026
Immix Biopharma prices $125M stock offering to fund AL amyloidosis therapy development

Immix Biopharma has priced an underwritten public offering of 11,363,637 shares of common stock at $11.00 per share, expecting gross proceeds of $125 million before deducting underwriting discounts and expenses. The offering is expected to close on or about 30 September 2026. The company intends to use the net proceeds to fund development of NXC-201, working capital, and general corporate purposes. NXC-201 is a CAR-T cell therapy being evaluated for relapsed/refractory AL Amyloidosis and has received Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy designation from the US FDA. J.P. Morgan is acting as sole book-running manager. The offering included participation from institutional investors including Eventide Asset Management, Janus Henderson Investors, Ridgeback Capital Investments, and Wellington Management.